Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion type Assertion NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_head.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion description "[Furthermore, both HIV and HCV NAT performance were associated with significantly higher odds of being high utilizers (HIV odds ratio 1.58, HCV 2.69, p < 0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_provenance.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion evidence source_evidence_literature NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_provenance.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion SIO_000772 19422344 NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_provenance.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion wasDerivedFrom befree-2016 NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_provenance.
- NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_assertion wasGeneratedBy ECO_0000203 NP737105.RAeu0trLlwDe5eLv2-VC3RP7PoFl1wfklxhPvDCHxOBpc130_provenance.